ROLE OF HELICOBACTER PYLORI ERADICATION USING CLARITHROMYCIN-BASED TRIPLE THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
Last updated: 25 Dec 2024
10.21608/bfsa.2022.271687
eradication, Helicobacter pylori, Irritable bowel syndrome, quality of life, Triple therapy
Haidi Karam-Allah
Ramadan
Tropical Medicine and Gastroenterology, Faulty of Medicine, Assiut University.
haidikaram@aun.edu.eg
Gellan
Ahmed
K.
Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt -Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
Waleed
Hassan
Attia
Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut, Egypt
45
2
37882
2022-12-01
2022-05-22
2022-12-01
859
868
1110-0052
3009-7703
https://bpsa.journals.ekb.eg/article_271687.html
https://bpsa.journals.ekb.eg/service?article_code=271687
271,687
Original Article
1,096
Journal
Bulletin of Pharmaceutical Sciences Assiut University
https://bpsa.journals.ekb.eg/
ROLE OF HELICOBACTER PYLORI ERADICATION USING CLARITHROMYCIN-BASED TRIPLE THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
Details
Type
Article
Created At
22 Jan 2023